Form 8-K - Current report:
SEC Accession No. 0001564590-20-043007
Filing Date
2020-09-09
Accepted
2020-09-09 17:00:35
Documents
12
Period of Report
2020-09-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K 090920 alks-8k_20200909.htm   iXBRL 8-K 37550
  Complete submission text file 0001564590-20-043007.txt   166721

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alks-20200909.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20200909_lab.xml EX-101.LAB 19413
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20200909_pre.xml EX-101.PRE 11606
5 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20200909_htm.xml XML 3531
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 201167033
SIC: 2834 Pharmaceutical Preparations